According to Zen Score, the 3 best drug store stocks to buy right now are:
1. Leafly Holdings (NASDAQ:LFLY)
Leafly Holdings (NASDAQ:LFLY) is the top pharmaceutical retailer stock with a Zen Score of 35, which is 11 points higher than the pharmaceutical retailer industry average of 24. It passed 11 out of 33 due diligence checks and has average fundamentals. Leafly Holdings has seen its stock lose -55.49% over the past year, overperforming other pharmaceutical retailer stocks by 1 percentage points.
Leafly Holdings has an average 1 year
price target of $60.00, an upside of 834.58% from Leafly Holdings's current stock price of $6.42.
Leafly Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Leafly Holdings, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Petmed Express (NASDAQ:PETS)
Petmed Express (NASDAQ:PETS) is the second best pharmaceutical retailer stock with a Zen Score of 34, which is 10 points higher than the pharmaceutical retailer industry average of 24. It passed 11 out of 38 due diligence checks and has average fundamentals. Petmed Express has seen its stock lose -48% over the past year, overperforming other pharmaceutical retailer stocks by 9 percentage points.
Petmed Express has an average 1 year
price target of $18.50, an upside of 80.49% from Petmed Express's current stock price of $10.25.
Petmed Express stock has a consensus Hold recommendation according to Wall Street analysts. Of the 2 analysts covering Petmed Express, 50% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 50% have issued a Strong Sell.
3. Walgreens Boots Alliance (NASDAQ:WBA)
Walgreens Boots Alliance (NASDAQ:WBA) is the third best pharmaceutical retailer stock with a Zen Score of 32, which is 8 points higher than the pharmaceutical retailer industry average of 24. It passed 10 out of 38 due diligence checks and has average fundamentals. Walgreens Boots Alliance has seen its stock lose -29.51% over the past year, overperforming other pharmaceutical retailer stocks by 27 percentage points.
Walgreens Boots Alliance has an average 1 year
price target of $32.40, an upside of 45.68% from Walgreens Boots Alliance's current stock price of $22.24.
Walgreens Boots Alliance stock has a consensus Hold recommendation according to Wall Street analysts. Of the 10 analysts covering Walgreens Boots Alliance, 0% have issued a Strong Buy rating, 10% have issued a Buy, 80% have issued a hold, while 0% have issued a Sell rating, and 10% have issued a Strong Sell.